To understand the prevalence of Respiratory diseases in Asia.
- Conditions
- Health Condition 1: null- adult patients receiving care for either asthma, allergic rhinitis (AR), chronic obstructive pulmonary disease (COPD), or rhinosinusitis
- Registration Number
- CTRI/2013/02/003386
- Lead Sponsor
- MSD Pharmaceuticals Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 5250
A subject must meet all the criteria listed below to be eligible.
1.Each subject (or subjects legal representative) must be willing and able to provide written informed consent for the study.
2.Each subject must be greater than equal to 18 years of age. A subject may be of either sex, and any race or ethnicity.
3.Each subject must have presented to the study site to receive care for a new or existing diagnosis of asthma, allergic rhinitis, COPD or rhinosinusitis.
4.
Each subject must be capable of reading and/or comprehending one of the languages of the Informed Consent Form (ICF) and patient survey documents.
A subject meeting any of the exclusion criteria listed below must be excluded from participating in the study:
The subject has participated in any interventional clinical study within the 12 weeks prior to entering the current study.
The subject or a family member is among the personnel of the investigational or Sponsor staff directly involved with this study.
The subject was screened and consented (enrolled) to participate in this study at a previous visit to the physician or at any other study site.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method